Matrix of progression

See the matrix below for all STs, grouped into 1-2, 3-5 and 6-7.

ST1-2

ST3-5

ST6-7

† Surgical management of retained products of conception (Obstetrics)- surgical evacuation of retained products of conception after 16 weeks gestation using suction curettage or a surgical curette

¥ Surgical techniques used by the trainee to control postpartum haemorrhage, including intra-uterine balloons, brace sutures, uterine packing  and hysterectomy

Ω Caesarean section complexity

• Examples of ‘basic’: first or second caesarean section with longitudinal lie
• Examples of ‘intermediate’: are twins/transverse lie and preterm more than 28 weeks
• Examples of ‘complex’:  preterm less than 28 weeks/grade 4 placenta praevia and fibroids in lower uterine segment

* Procedures added to the 2019 matrix, not previously requiring summative OSATs in the 2013 (post-implementation phase)

The 2019 curriculum has now been in use for over 12 months. As before, a trainee will be expected to have completed at least three competent summative OSATs (one supervised by a consultant) for all the procedures listed in the matrix for the training year they are completing, including procedures new to the matrix in 2019. Trainees who have returned to training for less than 12 whole time equivalent months since the introduction of the 2019 curriculum, because of OOP, maternity leave or long periods of ill health, will only need to have one summative OSAT showing competency in the procedures that were added in as new requirements for their training year in 2019.  TPDs will use discretion where a trainee has returned from training if the period of time left of that training year is very short.

Where the pandemic has interfered with access to training and assessment of a particular procedure, meaning that the matrix requirements have not been met, the ARCP panel can use one of the novel Covid outcomes, 10.1 or 10.2.

** The MRCOG examinations are only derogated for those trainees who have not yet had an opportunity to sit them. Part 1 and Part 2 MRCOG have already resumed.  Trainees reaching a critical way point who have not yet had an opportunity to take the examination can be awarded an outcome 10.1 C1 if all other non-derogated curriculum requirements have been met.

*** Courses with a face-to-face component

Courses with a major face-to-face component were derogated during the first wave of the pandemic. There has since been a move to on-line versions of these courses and their content. ST1 trainees will be expected to show evidence of on-line eLearning regarding CTG interpretation.  All other courses will remain derogated until the RCOG and GMC decide on a return to the prepandemic matrix. However, trainees will be expected to access all these courses during their training eventually  and would be advised to access as many as they can in their new formats as soon as possible (appropriate to their stage of training).  When the derogation of courses is lifted, a year will be given for trainees to access the courses they should have done according to the prepandemic matrix,  if they have not done so already.

Further guidance on evidence required for CiPs in the Core Curriculum

The philosophy of the new curriculum is about quality of evidence rather than quantity and a move away from absolute numbers of workplace based assessments (WBAs) and the tick box approach and the new training matrix above demonstrates this.

The CiP guides developed are available for trainers and trainees to give information about what would be appropriate evidence at different stages of training CiP guides.

Rules for CiPs:

1. There must be some evidence linked to each CiP in each training year to show development in the CiP area.
    
2. In each stage of training (Basic ST1-2, Intermediate ST3-5, Advanced ST6-7) the expectation is that there should be a minimum of one piece of evidence linked to each key skill for all clinical and non-clinical CiPs. This evidence needs to be appropriate for the stage of training.

Expected progress for clinical CiPs

Expected progress for clinical CiPs

Expected progress for clinical CiPs